Innate Pharma (Innate Pharma) Days Sales Outstanding : 388.20 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Innate Pharma Days Sales Outstanding?

Innate Pharma's average Accounts Receivable for the six months ended in Dec. 2023 was $38.41 Mil. Innate Pharma's Revenue for the six months ended in Dec. 2023 was $18.06 Mil. Hence, Innate Pharma's Days Sales Outstanding for the six months ended in Dec. 2023 was 388.20.

The historical rank and industry rank for Innate Pharma's Days Sales Outstanding or its related term are showing as below:

IPHA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.49 Med: 60.48 Max: 486.73
Current: 173.19

During the past 13 years, Innate Pharma's highest Days Sales Outstanding was 486.73. The lowest was 9.49. And the median was 60.48.

IPHA's Days Sales Outstanding is ranked worse than
80.65% of 889 companies
in the Biotechnology industry
Industry Median: 71.03 vs IPHA: 173.19

Innate Pharma's Days Sales Outstanding increased from Dec. 2022 (127.69) to Dec. 2023 (388.20).

Innate Pharma Days Sales Outstanding Historical Data

The historical data trend for Innate Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innate Pharma Days Sales Outstanding Chart

Innate Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

56.72

90.03

184.49

14.66

64.09

Innate Pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															285.31	20.94	127.69	151.23	388.20

Competitive Comparison of Innate Pharma's Days Sales Outstanding

For the Biotechnology subindustry, Innate Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innate Pharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innate Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Innate Pharma's Days Sales Outstanding falls into.

Innate Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Innate Pharma's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.263	+	16.612)	/	2 )	/	56.599	*	365
=	9.9375					/	56.599	*	365
=	64.09

Innate Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (60.202	+	16.612)	/	2 )	/	18.056	*	365 / 2
=	38.407					/	18.056	*	365 / 2
=	388.20

Innate Pharma (NAS:IPHA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Innate Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Innate Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Innate Pharma (Innate Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innate Pharma SA (NAS:IPHA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IPHYF:USA 0EVI:UK IPH:France IDDA:Germany

Address

117, Avenue de Luminy, Marseille, FRA, 13009

Website

https://www.innate-pharma.com

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, avdoralimab, and others.